Shares of Merck slid Tuesday after the drugmaker surprised Wall Street with a lower-than-expected 2025 sales forecast due partly to a pause in shipments of one of its top-selling products to China.

Merck, with a 76.59% gross margin and $63.17 billion in revenue, continues expanding its global vaccine reach. Moreover, Merck announced a $0.81 quarterly dividend and a $10 billion stock buyback ...

Merck’s HPV vaccine – Gardasil – is facing a challenge in China amid lower demand. The decline in Gardasil sales, clubbed with increased competition for its diabetes drugs, has weighed on ...

As part of the announcement, Merck disclosed setbacks to Gardasil's sales, highlighting a 3% decrease in sales in 2024 and, more directly, a decrease of 18% in the fourth quarter, with the blame ...

We recently published a list of Jim Cramer Discussed These 12 Stocks Recently. In this article, we are going to take a look at where Merck & Co., Inc. (NYSE:MRK) stands against other stocks that ...

"You go online, you do commercials to ... pharmaceutical company Merck & Co. over allegations it failed to properly warn patients about risks associated with Gardasil, the vaccine that protects ...

Merck & Co Inc (MRK) reports robust sales growth driven by KEYTRUDA and WINREVAIR, while navigating GARDASIL demand issues in China. Brad Smith breaks down the top headlines on today's Market Minute ...

Merck & Co Inc (MRK) reports robust sales growth driven by KEYTRUDA and WINREVAIR, while navigating GARDASIL demand issues in China. Earnings are painting a mixed picture within the pharmaceutical ...

By pulling off the intricacies of her character, and portraying deep emotions, the actress turned out to ... audiences would like to see more of them in Commercial films.

For some fans, Super Bowl commercials are as big a part of the experience than the game itself. This year, prices for a 30-second spot got up to about $8 million in the weeks leading up to the game.